|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Brucella IgG ELISA | Amyloid Beta (1-42) (FL) ELISA Assay | Amyloid Beta (N3pE) ELISA Assay | Amyloid ß Toxic Oligomer ELISA Assay | C-Peptide ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB05018 | 27719 | 27716 | 27709 | IB79101 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgG antibodies directed against pathogenic Brucella ssp. in serum and plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß (1-42) in EDTA plasma cerebrospinal fluid and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Amyloid ß (N3pE-42) in brain tissue extract. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Amyloid ß Toxic Oligomer in cerebrospinal fluids. For research use only, not for use in diagnostic procedures. | Solid phase enzyme immunoassay (ELISA) for the determination of C-Peptide in serum, plasma and urine. For research use only, not for use in diagnostic procedures. |
| Detection Target | Brucella IgG | Aspergillus fumigatus IgG | Anti-Trastuzumab (Herceptin®) | Metanephrine / Normetanephrine | Dopamine |
| Sample Type | Serum and plasma (EDTA, citrate, heparin). | Serum, Blood Plasma | Serum and plasma. | Urine | Tissue Homogenates, Dialysates, Urine |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 1.56 to 100 pg/mL | 7.75 to 496 pg/mL | 3.13 to 200.0 pg/mL | 0.2 to 16.0 ng/mL |
| Sensitivity | > 92% | 100% (95% confidence interval: 83.16% - 100%) | 30 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 0.25 ng/mL x C (must be multipled by a correction factor dependent on sample volume). |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | Overnight + 1 hr 30 mins (incubation) | Overnight + 1 hr 30 mins (incubation) | 1 hr 30 mins (incubation) | 1 hr 50 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |